Publications by authors named "N A Bhowmick"

Article Synopsis
  • Transmembrane integrin-associated protein is shown to be a significant checkpoint in innate immunity that is elevated in cancer cells like melanoma, impacting anti-tumor responses.
  • Research utilized ATAC-Sequencing to uncover increased chromatin accessibility in the promoter region of this protein in melanoma versus normal cells.
  • The study identified the transcription factor NRF-1 as a key regulator binding to specific sites in the promoter region, which is crucial for the protein's upregulation during tumor progression.
View Article and Find Full Text PDF

The aim of the present study was three folds; (i) to correlate clinical case history with objective findings of a client presented with sternal discomfort along with odynophagia; (ii) to evaluate the cause for retrosternal discomfort using Functional Esophagoscopy (FE); and (iii) to reaffirm the Cook's (2008) algorithm for clinical diagnosis of esophageal dysphagia in single sitting using Transnasal Esophagoscopy (TNE). A 72 years old male (named 'G') visited a tertiary health care hospital with a complaint of imbalance for past 2 months. Also, had a complaint of pain while swallowing for the past 15 days along with left arm weakness (for past 2 days) and got admitted for treatment.

View Article and Find Full Text PDF

Chemotherapy is often combined with surgery for muscle invasive and nonmuscle invasive bladder cancer (BCa). However, 70% of the patients recur within 5 years. Metabolic reprogramming is an emerging hallmark in cancer chemoresistance.

View Article and Find Full Text PDF

Glutamine, a multifaceted nonessential/conditionally essential amino acid integral to cellular metabolism and immune function, holds pivotal importance in the landscape of cancer therapy. This review delves into the intricate dynamics surrounding both glutamine antagonism strategies and glutamine supplementation within the context of cancer treatment, emphasizing the critical role of glutamine metabolism in cancer progression and therapy. Glutamine antagonism, aiming to disrupt tumor growth by targeting critical metabolic pathways, is challenged by the adaptive nature of cancer cells and the complex metabolic microenvironment, potentially compromising its therapeutic efficacy.

View Article and Find Full Text PDF